PUBLISHER: Grand View Research | PRODUCT CODE: 1530394
PUBLISHER: Grand View Research | PRODUCT CODE: 1530394
Nattokinase Market Size, Share & Trends Analysis Report By Application, By Region, And Segment Forecasts, 2024 - 2030
Nattokinase Market Growth & Trends:
The global nattokinase market is expected to reach USD 40.1 million by 2030 and growing at a CAGR of 3.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. A major factor propelling the nattokinase market worldwide is the trend towards natural and functional supplements. Customers are looking for natural substitutes that have positive health impacts without unfavorable side effects due to growing cautious of synthetic ingredients. Nattokinase is a natural enzyme owing to which it is adoption is rising in supplement manufacturing. Another significant factor propelling the nattokinase market's sales is the growing customer inclination for supplements that promote general health and wellbeing.
A rising number of customers are looking for foods that offer health advantages over just basic nourishment. The demand for nattokinase has increased significantly as low-carb and gluten-free diets have become more and more popular. Many customers follow gluten-free diets for various health-related reasons, or they have been diagnosed with celiac disease. This market is expanding, and nattokinase is a great alternative to wheat flour in baking and cooking. Almond powder has also become more popular due to the ketogenic diet, which places a strong emphasis on consuming large amounts of fat and few carbohydrates. It is a mainstay in recipes that are keto-friendly due to its low carbohydrate level.
Nattokinase is being included in functional foods and beverages by the food and beverage sector. In addition to providing basic nutrition, these products are made to offer additional health benefits. the usage and market penetration of nattokinase is anticipated to increase owing to its rising incorporation into regular food products. Nattokinase is further utilized in the cosmetics business due to its possible anti-aging and skin health advantages. The enzyme is a useful component in skincare formulas owing to its capacity to promote blood flow and break blood clots, both of which can improve skin health.
Nutraceuticals application held the highest share of the market in 2023. The growing emphasis on health and wellness has driven a heightened consumer interest in natural and effective supplements to support well-being. Nutraceuticals, encompassing functional foods and dietary supplements, are increasingly favored for their perceived safety and health benefits. There is a global shift towards preventive healthcare, with consumers prioritizing measures to prevent diseases rather than merely treating them reactively. Nattokinase, renowned for its cardiovascular benefits, has thus gained prominence in the production of dietary supplements, contributing significantly to market expansion.
Major players in the nattokinase market include Japan Bio Science Laboratory Co., Ltd., Novonesis Group (MenaquinGold), Contek Life Science Co., Ltd., and others. Companies are taking various steps such as global expansion, partnerships, acquisitions & mergers, development & launch of new products, and others to gain more share of the market.
Nattokinase Market Report Highlights:
- Based on application, pharmaceuticals segment is expected to grow at a CAGR of 3.6% from 2024 to 2030. The increasing prevalence of chronic diseases, notably cardiovascular conditions, has surged the demand for efficient treatments. This trend is a significant driver propelling the nattokinase market forward.
- Asia Pacific is expected to grow at a CAGR of 3.5% from 2024 to 2030. The growing awareness regarding the significance of cardiovascular and overall health among consumers in the region is driving the market growth.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Application Outlook
- 2.3. Regional Outlook
- 2.4. Competitive Insights
Chapter 3. Nattokinase Market Variables, Trends & Scope
- 3.1. Market Introduction
- 3.2. Industry Value Chain Analysis
- 3.2.1. Profit Margin Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Industry Challenges
- 3.3.4. Industry Opportunities
- 3.4. Industry Analysis - Porter's Five Force Analysis
- 3.5. Market Entry Strategies
Chapter 4. Nattokinase Market: Application Estimates & Trend Analysis
- 4.1. Nutraceuticals
- 4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.2. Food Additives
- 4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3. Pharmaceutical
- 4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.4. Others
- 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Nattokinase Market: Regional Estimates & Trend Analysis
- 5.1. Regional Movement Analysis & Market Share, 2023 & 2030
- 5.2. North America
- 5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.2. U.S.
- 5.2.2.1. Key country dynamics
- 5.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.2.3. Canada
- 5.2.3.1. Key country dynamics
- 5.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3. Europe
- 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.2. UK
- 5.3.2.1. Key country dynamics
- 5.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.3. Germany
- 5.3.3.1. Key country dynamics
- 5.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.4. France
- 5.3.4.1. Key country dynamics
- 5.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.5. Spain
- 5.3.5.1. Key country dynamics
- 5.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.6. Italy
- 5.3.6.1. Key country dynamics
- 5.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4. Asia Pacific
- 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.2. China
- 5.4.2.1. Key country dynamics
- 5.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.3. Japan
- 5.4.3.1. Key country dynamics
- 5.4.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.4. Australia
- 5.4.4.1. Key country dynamics
- 5.4.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.4.5. South Korea
- 5.4.5.1. Key country dynamics
- 5.4.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.5. Central & South America
- 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.6. Middle East & Africa
- 5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Competitive Analysis
- 6.1. Recent developments & impact analysis, by key market participants
- 6.2. Company Categorization
- 6.3. Participant's Overview
- 6.4. Financial Performance
- 6.5. Product Benchmarking
- 6.6. Company Market Share Analysis, 2023 (%)
- 6.7. Company Heat Map Analysis
- 6.8. Strategy Mapping
- 6.9. Company Profiles
- 6.10. Japan Bio Science Laboratory Co., Ltd.
- 6.10.1. Company Overview
- 6.10.2. Financial Performance
- 6.10.3. Product Benchmarking
- 6.10.4. Strategic Initiatives
- 6.11. Novonesis Group (MenaquinGold)
- 6.11.1. Company Overview
- 6.11.2. Financial Performance
- 6.11.3. Product Benchmarking
- 6.11.4. Strategic Initiatives
- 6.12. Creative Enzymes
- 6.12.1. Company Overview
- 6.12.2. Financial Performance
- 6.12.3. Product Benchmarking
- 6.12.4. Strategic Initiatives
- 6.13. Weidan Biotechnology Co., Ltd.
- 6.13.1. Company Overview
- 6.13.2. Financial Performance
- 6.13.3. Product Benchmarking
- 6.13.4. Strategic Initiatives
- 6.14. BIO-CAT
- 6.14.1. Company Overview
- 6.14.2. Financial Performance
- 6.14.3. Product Benchmarking
- 6.14.4. Strategic Initiatives
- 6.15. Bioven Ingredients
- 6.15.1. Company Overview
- 6.15.2. Financial Performance
- 6.15.3. Product Benchmarking
- 6.15.4. Strategic Initiatives
- 6.16. Eiffel Biotech
- 6.16.1. Company Overview
- 6.16.2. Financial Performance
- 6.16.3. Product Benchmarking
- 6.16.4. Strategic Initiatives
- 6.17. Daiwa Pharmaceutical Co. Ltd.
- 6.17.1. Company Overview
- 6.17.2. Financial Performance
- 6.17.3. Product Benchmarking
- 6.17.4. Strategic Initiatives
- 6.18. Contek Life Science Co., Ltd.
- 6.18.1. Company Overview
- 6.18.2. Financial Performance
- 6.18.3. Product Benchmarking
- 6.18.4. Strategic Initiatives
- 6.19. Sungen Bioscience Co., Ltd
- 6.19.1. Company Overview
- 6.19.2. Financial Performance
- 6.19.3. Product Benchmarking
- 6.19.4. Strategic Initiatives
List of Tables
- 1. Nattokinase market - Key market driver analysis
- 2. Nattokinase market - Key market restraint analysis
- 3. Nattokinase market estimates and forecast for nutraceuticals, 2018 - 2030 (USD Millions)
- 4. Nattokinase market estimates and forecast for food additives, 2018 - 2030 (USD Millions)
- 5. Nattokinase market estimates and forecast for pharmaceuticals, 2018 - 2030 (USD Millions)
- 6. Nattokinase market estimates and forecast for other applications, 2018 - 2030 (USD Millions)
- 7. North America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 8. North America nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 9. U.S. macro-economic outlay
- 10. U.S. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 11. U.S. nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 12. Canada macro-economic outlay
- 13. Canada nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 14. Canada nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 15. Europe nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 16. Europe nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 17. Germany macro-economic outlay
- 18. Germany nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 19. U.K. macro-economic outlay
- 20. U.K. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 21. U.K. nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 22. Spain macro-economic outlay
- 23. Spain nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 24. Spain nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 25. Italy macro-economic outlay
- 26. Italy nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 27. Italy nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 28. France macro-economic outlay
- 29. France nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 30. France nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 31. Asia Pacific nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 32. Asia Pacific nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 33. China macro-economic outlay
- 34. China nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 35. China nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 36. Australia macro-economic outlay
- 37. Asutralia nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 38. Australia nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 39. Japan macro-economic outlay
- 40. Japan nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 41. Japan nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 42. South Korea macro-economic outlay
- 43. South Korea nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 44. South Korea nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 45. Central & South America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 46. Central & South America nattokinase market revenue estimates and forecast, by source, 2018 - 2030 (USD Millions)
- 47. Central & South America nattokinase market revenue estimates and forecast, by form, 2018 - 2030 (USD Millions)
- 48. Central & South America nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
- 49. Middle East & Africa nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 50. Middle East & Africa nattokinase market revenue estimates and forecast, by source, 2018 - 2030 (USD Millions)
- 51. Middle East & Africa nattokinase market revenue estimates and forecast, by form, 2018 - 2030 (USD Millions)
- 52. Middle East & Africa nattokinase market revenue estimates and forecast, by application, 2018 - 2030 (USD Millions)
List of Figures
- 1. Nattokinase market snapshot
- 2. Nattokinase market segmentation & scope
- 3. Nattokinase market penetration & growth prospect mapping
- 4. Nattokinase market value chain analysis
- 5. Nattokinase market dynamics
- 6. Nattokinase market Porter's Five Forces analysis
- 7. Nattokinase market: Application movement analysis, 2023 & 2030 (%)
- 8. Nattokinase in animal feed market estimates and forecast, 2018 - 2030 (USD Millions)
- 9. Nattokinase market estimates and forecast for nutraceuticals, 2018 - 2030 (USD Millions)
- 10. Nattokinase market estimates and forecast for food additives, 2018 - 2030 (USD Millions)
- 11. Nattokinase market estimates and forecast for pharmaceuticals, 2018 - 2030 (USD Millions)
- 12. Nattokinase market estimates and forecast for other applications, 2018 - 2030 (USD Millions)
- 13. Nattokinase market: Regional movement analysis, 2023 & 2030 (%)
- 14. North America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 15. U.S. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 16. Canada nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 17. Europe nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 18. Germany nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 19. U.K. nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 20. Spain nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 21. Italy nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 22. France nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 23. Asia Pacific nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 24. China nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 25. Australia nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 26. Japan nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 27. South Korea nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 28. Central & South America nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
- 29. Middle East & Africa nattokinase market estimates and forecast, 2018 - 2030 (USD Millions)
